Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-Factor IX substitute, BIIB029 Vector   (CAT#: GTVCR-WQ711MR)

This product GTVCR-WQ711MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting Factor IX substitute. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Homo sapiens
RefSeq NM_000133.5
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 2158
UniProt ID P00740
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-Factor IX substitute, BIIB029 Vector (GTVCR-WQ711MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ288MR IVTScrip™ pT7-VEE-mRNA-Anti-IL1B, ACZ885 Vector Vector ACZ885
GTVCR-WQ1847MR IVTScrip™ pT7-VEE-mRNA-Anti-ERBB2&ERBB3, MCLA-128 Vector Vector MCLA-128
GTVCR-WQ555MR IVTScrip™ pT7-VEE-mRNA-Anti-alpha toxin&<br />lukE, ASN-1 Vector Vector ASN-1
GTVCR-WQ1120MR IVTScrip™ pT7-VEE-mRNA-Anti-MUC16, DMUC5754A Vector Vector DMUC5754A
GTVCR-WQ1477MR IVTScrip™ pSP6-VEE-mRNA-Anti-PDCD1, IBI-308 Vector Vector IBI-308
GTVCR-WQ1716MR IVTScrip™ pT7-VEE-mRNA-Anti-MS4A1, LFB-R603 Vector Vector LFB-R603
GTVCR-WQ810MR IVTScrip™ pSP6-VEE-mRNA-Anti-DPP4, BT 5/9 Vector Vector BT 5/9
GTVCR-WQ907MR IVTScrip™ pT7-VEE-mRNA-Anti-CD2, CD58-Fc Vector Vector CD58-Fc
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.